IE
EPRS

Israel Englander’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Israel Englander’s Portfolio EPRS Stock Details EPRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-411,111
Closed -$1.11M – 3965
2016
Q1 		$1.11M Sell
411,111
-29,143
-7% -$81.8K ﹤0.01% 2131
2015
Q4 		$1.36M Sell
440,254
-30,986
-7% -$140K ﹤0.01% 2150
2015
Q3 		$2.08M Buy
471,240
+378,951
+411% +$2.23M ﹤0.01% 1877
2015
Q2 		$527K Buy
92,289
+36,515
+65% +$249K ﹤0.01% 2618
2015
Q1 		$499K Buy
+55,774
New +$448K ﹤0.01% 2759

Other funds holding EPRS

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Israel Englander's EPRS Position: Q2 2016 in Review

Israel Englander sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q2 2016, closing a stake of 411,111 shares — an estimated $1.11M sold.

Israel Englander first reported a position in EPRS in Q1 2015 and held it in 5 quarters. The position peaked at $2.08M in Q3 2015. 32 funds tracked by Wall St. Rank hold EPRS as of Q2 2016.

  • Israel Englander reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Israel Englander sold 411,111 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q2 2016, an estimated $1.11M.
  • Israel Englander first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q1 2015 and held it in 5 quarters.
  • Israel Englander's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $2.08M in Q3 2015.
  • 32 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q2 2016.

Based on Millennium Management's 13F filing for Q2 2016, filed 15 Aug 2016.